Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sera Prognostics, Inc. (SERA)

1.53   0.07 (4.79%) 01-27 13:48
Open: 1.5331 Pre. Close: 1.46
High: 1.53 Low: 1.5
Volume: 1,270 Market Cap: 47(M)

Technical analysis

as of: 2023-01-27 4:47:52 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.93     One year: 2.26
Support: Support1: 1.31    Support2: 1.1
Resistance: Resistance1: 1.65    Resistance2: 1.93
Pivot: 1.5
Moving Average: MA(5): 1.47     MA(20): 1.45
MA(100): 1.48     MA(250): 2.28
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 65.8     %D(3): 63
RSI: RSI(14): 54.6
52-week: High: 7.71  Low: 1.1
Average Vol(K): 3-Month: 31 (K)  10-Days: 5 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SERA ] has closed below upper band by 39.4%. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.54 - 1.54 1.54 - 1.55
Low: 1.51 - 1.52 1.52 - 1.53
Close: 1.51 - 1.53 1.53 - 1.55

Company Description

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Headline News

Sun, 29 Jan 2023
Risa Sera Talks Prominence, STARDOM, Wrestling Overseas, And More | Interview - Fightful

Sun, 29 Jan 2023
Smriti Irani shares emotional video of kids singing Que Sera Sera - Hindustan Times

Wed, 25 Jan 2023
Threats over high natural gas bills shutter Deming City Hall; some ... - Albuquerque Journal

Wed, 25 Jan 2023
Karol G Declares ‘Mañana Será Bonito’ — With Help From Some Cute Kids — in New Album Announcement - Variety

Sun, 22 Jan 2023
Sera Aintablian Remembered at Hovsepian School - The Armenian Mirror-Spectator

Fri, 20 Jan 2023
Friday and Saturday takeout and delivery specials from Bar Lucca ... -

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 0 (M)
Shares Float 30 (M)
% Held by Insiders 1.76e+007 (%)
% Held by Institutions 14.8 (%)
Shares Short 83 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -4.708e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -20
Return on Assets (ttm) 865
Return on Equity (ttm) -22.2
Qtrly Rev. Growth 229000
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.92
Qtrly Earnings Growth -1.9
Operating Cash Flow 0 (M)
Levered Free Cash Flow -37 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 722.8
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 67510
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.